Sihuan Pharmaceutical Holdings jumped 25% to HK$5.77 (US$.73) in the first day of trading following its IPO, giving more evidence that Hong Kong is the current worldwide center for warm receptions to pharmaceutical stock offerings. The company’s IPO was priced at HK$4.60, representing a forward P/E ratio of 27, and it hit a high of HK$6.05 in pre-market activity. Sihuan said demand for the offering was 481 times the number of shares in the deal. More details....

Stock Symbol: (HKEX: 0460)